Brixadi (buprenorphine) is a prescription injection that’s used to treat opioid use disorder (OUD). It comes as a solution in prefilled syringes and is given weekly or monthly by a healthcare ...

Brixadi (buprenorphine) is a prescription drug used to treat opioid use disorder in adults. Brixadi can cause side effects that range from mild to serious. Examples include headache, constipation, and ...

BRIXADI is now available for healthcare settings and pharmacies through a restricted distribution program called the BRIXADI REMS and is administered only by a healthcare professional. PLYMOUTH ...

Credit: Braeburn. Brixadi (weekly) and Brixadi (monthly) are different formulations. Brixadi ® (buprenorphine) extended-release subcutaneous injection is now available for the treatment of moderate to ...

BRIXADI is the first and only long-acting buprenorphine injectable with both weekly and monthly doses. Patients currently on a transmucosal buprenorphine-containing product can be switched to an ...

Please provide your email address to receive an email when new articles are posted on . Brixadi is the first long-acting buprenorphine injectable that is available in weekly and monthly doses.

The cost of Brixadi can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Brixadi. As with all medications, ...

Braeburn Inc. announces positive post-hoc analyses results from the randomized, double-blind, double-dummy phase 3 study of Brixadi (buprenorphine) extended-release weekly and monthly injections for ...

Brixadi (buprenorphine) is a brand-name injection that’s prescribed for opioid use disorder. As with other drugs, Brixadi can cause side effects, such as injection site reactions and respiratory ...